Which CLL drug combo gives best value for older patients?
NCT ID NCT02414022
First seen May 12, 2026 · Last updated May 12, 2026
Summary
This study looked at the costs and quality-of-life benefits of three different drug combinations for older adults (65 and up) with chronic lymphocytic leukemia (CLL). Researchers compared a standard chemo-immunotherapy (bendamustine plus rituximab) with two newer ibrutinib-based regimens. The goal was to see which treatment offers the best value for the Canadian healthcare system by measuring quality-adjusted life-years (QALYs) and overall costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
-
CHUM-CEntre Hospitalier de l'Universite de Montreal
Montreal, Quebec, Canada
-
CSSS Champlain-Charles LeMoyne
Greenfield Park, Quebec, Canada
-
Health Sciences North
Greater Sudbury, Ontario, Canada
-
Humber River Hospital
Toronto, Ontario, Canada
-
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
-
Kingston Health Sciences Centre
Kingston, Ontario, K7L3N6, Canada
-
London Regional Cancer Program
London, Ontario, Canada
-
Odette Cancer Centre Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
-
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
-
Stronach Regional Health Centre at Southlake
Newmarket, Ontario, L3Y 2P9, Canada
-
The Jewish General Hospital
Montreal, Quebec, Canada
-
The Moncton Hospital
Moncton, New Brunswick, Canada
-
Tom Baker Cancer Centre
Calgary, Alberta, Canada
-
University Health Network Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.